VanX is a zinc-dependent <
FONT SIZE="-1">D-Ala-
D-Ala amino dipeptidase required
for high-level resistanceto vancomycin. The enzyme is also able to process dipeptides with bulky C-terminal amino acids [Wu,Z.,
Wright, G. D., and Walsh, C. T. (1995)
Biochemistry 34, 2455-2463]. We took advantage o
f thisobservation to design and synthesize the dipeptide-like
D-Ala-
D-Gly(S
![](/images/gi<font color=)
fchars/Phi.gi
f" BORDER=0 >
p-CHF
2)-OH (
7) as a potentialmechanism-based inhibitor. VanX-mediated peptide cleavage generates a highly reactive 4-thioquinone
fluoromethide which is able to covalently react with enzyme nucleophilic residues, resulting in irreversibleinhibition. Inhibition o
f VanX by
7 was time-dependent (
Kirr = 30 ± 1
![](/images/entities/mgr.gi<font color=)
f">M;
kinact = 7.3 ± 0.3 min
-1) andactive site-directed, as deduced
from substrate protection experiments. Nucleophilic compounds such assodium azide, potassium cyanide, and glutathione did not protect the enzyme
from inhibition, indicatingthat the generated nucleophile inactivates VanX be
fore leaving the active site. The
failure to reactivatethe dead enzyme by gel
filtration or pH modi
fication con
firmed the covalent nature o
f the reaction thatleads to inactivation. Inactivation was associated with the elimination o
f fluoride ion as deduced
from
19FNMR spectroscopy analysis and with the production o
f fluorinated thiophenol dimer
12. These data areconsistent with suicide inactivation o
f VanX by dipeptide
7. The small size o
f the VanX active site andthe presence o
f a number o
f nucleophilic side chains at the opening o
f the active site gorge [Bussiere, D.E., et al
. (1998)
Mol. Cell 2, 75-84] associated with the high observed partition ratio o
f 7500 ± 500suggest that the inhibitor is likely to react at the entrance o
f the active site cavity.